Photodegradation of methylcobalamin and its determination in a commercial formulation

A. H. Chamle, N. L.J. Shane, A. Pai, B. S. Muddukrishna

Research output: Contribution to journalArticle

Abstract

Methylcobalamin is a highly photolabile and unstable molecule and hence, studies regarding photodegradation of methylcobalamin were carried out.. In order to investigate the stability studies, the drug was subjected to photodegradation by exposing it to different light conditions in the validated photostability chamber as per ICH Q1B guideline. The drug was found to be less degraded in the blue light and was more prone to degradation under fluorescent light. Validated stability indicating liquid chromatography method was used for separating the methylcobalamin and its degradation products. The methylcobalamin peak with a retention time of 2.978 min was observed to decrease with a commensurate increase in a degradant peak at 4 min. The observed degradant peak was suspected to be hydroxocobalamin and was further confirmed by molecular weight determination. The fractions collected from high performance liquid chromatography were later injected into mass detector to determine the mass of the degradation products, which was found to be 665.78 amu.

Original languageEnglish
Pages (from-to)57-62
Number of pages6
JournalIndian Journal of Pharmaceutical Sciences
Volume81
Issue number1
DOIs
Publication statusPublished - 01-01-2019

Fingerprint

Photolysis
Light
Hydroxocobalamin
Drug Stability
Liquid Chromatography
Molecular Weight
High Pressure Liquid Chromatography
Guidelines
mecobalamin
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

@article{9d867e42edc24dd29a3c2fd7fca51a2a,
title = "Photodegradation of methylcobalamin and its determination in a commercial formulation",
abstract = "Methylcobalamin is a highly photolabile and unstable molecule and hence, studies regarding photodegradation of methylcobalamin were carried out.. In order to investigate the stability studies, the drug was subjected to photodegradation by exposing it to different light conditions in the validated photostability chamber as per ICH Q1B guideline. The drug was found to be less degraded in the blue light and was more prone to degradation under fluorescent light. Validated stability indicating liquid chromatography method was used for separating the methylcobalamin and its degradation products. The methylcobalamin peak with a retention time of 2.978 min was observed to decrease with a commensurate increase in a degradant peak at 4 min. The observed degradant peak was suspected to be hydroxocobalamin and was further confirmed by molecular weight determination. The fractions collected from high performance liquid chromatography were later injected into mass detector to determine the mass of the degradation products, which was found to be 665.78 amu.",
author = "Chamle, {A. H.} and Shane, {N. L.J.} and A. Pai and Muddukrishna, {B. S.}",
year = "2019",
month = "1",
day = "1",
doi = "10.4172/pharmaceutical-sciences.1000479",
language = "English",
volume = "81",
pages = "57--62",
journal = "Indian Journal of Pharmaceutical Sciences",
issn = "0250-474X",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "1",

}

Photodegradation of methylcobalamin and its determination in a commercial formulation. / Chamle, A. H.; Shane, N. L.J.; Pai, A.; Muddukrishna, B. S.

In: Indian Journal of Pharmaceutical Sciences, Vol. 81, No. 1, 01.01.2019, p. 57-62.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Photodegradation of methylcobalamin and its determination in a commercial formulation

AU - Chamle, A. H.

AU - Shane, N. L.J.

AU - Pai, A.

AU - Muddukrishna, B. S.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Methylcobalamin is a highly photolabile and unstable molecule and hence, studies regarding photodegradation of methylcobalamin were carried out.. In order to investigate the stability studies, the drug was subjected to photodegradation by exposing it to different light conditions in the validated photostability chamber as per ICH Q1B guideline. The drug was found to be less degraded in the blue light and was more prone to degradation under fluorescent light. Validated stability indicating liquid chromatography method was used for separating the methylcobalamin and its degradation products. The methylcobalamin peak with a retention time of 2.978 min was observed to decrease with a commensurate increase in a degradant peak at 4 min. The observed degradant peak was suspected to be hydroxocobalamin and was further confirmed by molecular weight determination. The fractions collected from high performance liquid chromatography were later injected into mass detector to determine the mass of the degradation products, which was found to be 665.78 amu.

AB - Methylcobalamin is a highly photolabile and unstable molecule and hence, studies regarding photodegradation of methylcobalamin were carried out.. In order to investigate the stability studies, the drug was subjected to photodegradation by exposing it to different light conditions in the validated photostability chamber as per ICH Q1B guideline. The drug was found to be less degraded in the blue light and was more prone to degradation under fluorescent light. Validated stability indicating liquid chromatography method was used for separating the methylcobalamin and its degradation products. The methylcobalamin peak with a retention time of 2.978 min was observed to decrease with a commensurate increase in a degradant peak at 4 min. The observed degradant peak was suspected to be hydroxocobalamin and was further confirmed by molecular weight determination. The fractions collected from high performance liquid chromatography were later injected into mass detector to determine the mass of the degradation products, which was found to be 665.78 amu.

UR - http://www.scopus.com/inward/record.url?scp=85063724029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063724029&partnerID=8YFLogxK

U2 - 10.4172/pharmaceutical-sciences.1000479

DO - 10.4172/pharmaceutical-sciences.1000479

M3 - Article

VL - 81

SP - 57

EP - 62

JO - Indian Journal of Pharmaceutical Sciences

JF - Indian Journal of Pharmaceutical Sciences

SN - 0250-474X

IS - 1

ER -